EX-FILING FEES 3 ex_652379.htm EXHIBIT FILING FEES

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-1

(Form Type)

 

Panbela Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

 

 

Security Type

 

Security Class Title

 

Fee Calculation

Rule

 

Amount

Registered

 

Proposed

Maximum

Offering Price

Per Unit

 

Maximum

Aggregate

Offering Price
(1)

 

Fee Rate

 

Amount of

Registration

Fee

Fees to be Paid

Equity

 

Common stock, $0.001 par value per share(2)

 

Rule 457(o)

         

$17,250,000(3)(4)

 

0.00014760

 

$2,547

 

Equity

 

Class G common stock purchase warrants(5)

 

Other

                   
 

Equity

 

Common stock, $0.001 par value per share, underlying Class G common stock purchase warrants

 

Rule 457(o)

         

$17,250,000(4)

 

0.00014760

 

$2,547

  Equity   Class H common stock purchase warrants(5)                        
  Equity   Common stock, $0.001 par value per share, underlying Class H common stock purchase warrants               $8,625,000(4)   0.00014760   $1,273
  Equity   Pre-funded warrants(5)   Other                    
  Equity   Common stock, $0.001 par value per share, underlying pre-funded warrants   Rule 457(o)           –(3)   0.00014760  
  Total Offering Amounts           $43,125,000       $6,367
  Total Fees Previously Paid                  
  Total Fee Offsets                  
  Net Fee Due                   $6,367

 

 

 


(1)  Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) of the Securities Act of 1933, as amended (the “Securities Act”).

(2)  Pursuant to Rule 416 under the Securities Act, the shares of common stock registered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock split, stock dividends, recapitalizations, or other similar transactions.

(3)  The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock, common warrants and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $17,500,000.

(4)  Includes up to an additional 15% of the aggregate offering price to cover the underwriter’s option to purchase securities to cover over-allotments, if any.

(5)  No fee pursuant to Rule 457(g) of the Securities Act.